Posted on 11/4/19
Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split
NEW YORK, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it . . .
Posted on 11/3/19
BioHiTech Global Announces Research Coverage by Spartan Capital Securities
BioHiTech Global, Inc. (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced that Spartan Capital Securities, LLC. ("Spartan Capital") . . .
Posted on 11/1/19
These Biotechs Were Focused on One Line on Pfizer’s Earnings Report
The $79 million that Vyndaqel contributed to Pfizer's (NYSE:PFE) third-quarter revenue doesn't mean a whole lot to the pharmaceutical giant. It amounted to a whopping 0.6% . . .
Posted on 11/1/19
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
Just two weeks ago, Bristol-Myers Squibb's (NYSE:BMY) share price was barely where it was at the beginning of 2019. But the big drugmaker reported some positive . . .
Posted on 10/31/19
Henry Schein Announces $400 Million Increase to Share Repurchase Plan
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that . . .
Posted on 10/31/19
Klara Announces Partnership and Integration with Nextech Systems
Klara (www.klara.com), the New York based leader in secure patient communication, is proud to announce a new partnership with Nextech Systems (https://www.nextech.com/), a leading provider of . . .
Posted on 10/31/19
Celgene Reports Third Quarter 2019 Operating and Financial Results
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported third quarter 2019 total revenue of $4,520 million, a 16 percent increase compared to $3,892 million in the third . . .
Posted on 10/31/19
Oyster Point Pharma Announces Pricing of Initial Public Offering
PRINCETON, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical . . .
Posted on 10/31/19
Sell Celgene, Buy Bristol-Myers: Counting The Profits At The Halfway Mark
Summary There has been much debate whether it is best to hold shares in Celgene or Bristol-Myers. Back in July, I made a case for selling . . .
Posted on 10/31/19
Merck: Raising My Fair Value Estimate Once Again
SummaryMRK reported a great sales effort in Q3, marred only by a writedown that the Street is ignoring.Keytruda is demonstrating amazing sales momentum, and looks to . . .
Posted on 10/31/19
Better Buy: Johnson & Johnson vs. GlaxoSmithKline
Perspective matters when choosing between stocks to buy. For example, you might think that GlaxoSmithKline (NYSE:GSK) stands head and shoulders above Johnson & Johnson (NYSE:JNJ) based . . .
Posted on 10/31/19
Dow Jones News: No Asbestos for Johnson & Johnson; Apple Weak Ahead of Earnings
The Dow Jones Industrial Average (DJINDICES:^DJI) had eked out a small gain by 1:20 p.m. EDT Wednesday, up just 0.06%. News that Chile had cancelled the . . .
Posted on 10/30/19
FCB Health Network Takes Best in Show and Large Agency of the Year at Medical Marketing & Media Awards
FCB Health Network continued its 2019 awards streak at Thursday's Medical Marketing & Media (MM&M) Awards, taking home 11 honors, including Titanium Best in Show and . . .
Posted on 10/30/19
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT
PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, . . .
Posted on 10/30/19
Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results . . .
Posted on 10/30/19
Pfizer's (PFE) CEO Albert Bourla on Q3 2019 Results - Earnings Call Transcript
Pfizer, Inc. (NYSE:PFE) Q3 2019 Earnings Conference Call October 29, 2019 10:00 AM ETCompany ParticipantsChuck Triano – Senior Vice President of Investor RelationsAlbert Bourla – Chief . . .
Posted on 10/30/19
Pfizer's Q3 Earnings: A Tale of 3 Companies That Investors Should Enjoy
Pfizer (NYSE:PFE) announced its third-quarter earnings results before the market opened on Tuesday. All you have to do is look at the stock's performance in the . . .
Posted on 10/30/19
Kubtec Medical Imaging Named "Innovator of the Month" by U.S. Sen. Chris Murphy
Kubtec Medical Imaging announced today that it has been named "Innovator of the Month" by U.S. Senator Chris Murphy (D-CT) in recognition of its work developing . . .
Posted on 10/30/19
National Kidney Foundation Awards Five Young Investigators Grants for Research
Five young scientists have been awarded the National Kidney Foundation (NKF) Young Investigator Research Grants to advance knowledge about the treatment and prevention of kidney disease . . .
Posted on 10/29/19
Merck Announces Third-Quarter 2019 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2019.“We achieved another . . .
Posted on 10/29/19
Pfizer's Latest Data For JAK Inhibitor Drug Lines It Up To Take On Rivals
SummaryPfizer achieved positive results from its phase 3 JADE MONO-1 study using Abrocitinib to treat patients with moderate to severe atopic dermatitis.The primary endpoint of the . . .
Posted on 10/29/19
Pfizer Takes Aim at Regeneron, and UnitedHealth's Earnings Update
Pfizer's latest phase 3 trial results put its promising eczema drug on a path to challenge Regeneron and Sanofi's $2 billion-per-year drug, Dupixent. Also, how Regenxbio . . .
Posted on 11/4/19
Dialyze Direct Partners with Arbor Research Collaborative for Health
Dialyze Direct, a leading kidney care innovation company specializing in advancements in home dialysis, today announced a collaboration with Arbor Research Collaborative for Health (Arbor Research) . . .
Posted on 10/28/19
Teligent Announces First Injectable Filing From New Manufacturing Facility
BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has filed a . . .
Posted on 10/28/19
Pharmacy Times and Parata Systems Reveal the 2019 Next-Generation Pharmacist Winners
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times, the industry-leading pharmacy resource, and Parata Systems, the founding partners of the Next-Generation Pharmacist awards, honored the 2019 winners, named at the . . .
New York
